Objective: Parkinson's disease (PD) is the world's second neurodegenerative disorder. Degeneration of dopaminergic neurons is the hallmark of the disease. Here is a novel approach to treat PD with a phenolic compound Sesamol (SA) and in combination with folic acid (FA).
Methods:The study was designed with five groups of animals and 6 rats in each group. The rats were infused with 6-hydroxydopamine (10 μg/2 μl in 0.1% ascorbic acid saline) once for the development of PD, Group 1 (control), Group 2 (lesion), Group 3 (lesion+SA), Group 4 (lesion+SA+FA), and Group 5 (lesion+L-dopa). The biochemical parameters such as glucose, triglycerides, protein, FA, thiobarbituric acid reactive substance (TBARS), and antioxidant profile in serum were estimated. The neurotransmitters level in striatum was estimated, and histopathology of striatum and midbrain tissues was carried out.
Results:The results showed that 6-hydroxydopamine induced lesion has a significant alteration in the level of glucose, triglycerides, protein and FA, whereas TBARS level was elevated and the activities of antioxidants and neurotransmitters level were reduced. This was significantly restored on SA and FA treatment. The lesion group shows an abnormal architecture of striatum and midbrain, whereas on SA and FA treatment there was minimal abnormality.Conclusion: Thus, our study demonstrates that SA has a neuroprotective effect against 6-hydroxydopamine insult and showed a synergic effect when combined with FA.